A Study of Adalimumab on Inflammatory Mediators Following a Systemic Endotoxin Challenge

Condition:   Healthy Interventions:   Drug: Adalimumab;   Drug: Lipopolysaccharide (LPS) Sponsor:   Janssen Research & Development, LLC Recruiting

Source: ClinicalTrials.gov - June 1, 2023 Category: Research Source Type: clinical trials